Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Wichit, Arpornwirat"'
Autor:
Anthony J. Good, Mark T. Marino, Nicholas J. Ede, Leslie Chong, Christoph C. Zielinski, Joshua Tobias, Mirjana Drinic, Teerapat Ungtrakul, Wen-Chi Chou, Li-Yuan Bai, Aumkhae Sookprasert, Jedzada Maneechavakajorn, Suebpong Tanasanvimon, Thomas Cheung Yau, Chia-Jui Yen, Chaiyut Charoentum, Wichit Arpornwirat, Arunee Dechaphunkul, Iurie Bulat, Marina Maglakelidze, Yee Chao, Erika Garner-Spitzer, Ursula Wiedermann
Supplementary Data 3 & 4
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aaf4da22beef67401032aee58a6e5653
https://doi.org/10.1158/1078-0432.22480941
https://doi.org/10.1158/1078-0432.22480941
Autor:
Anthony J. Good, Mark T. Marino, Nicholas J. Ede, Leslie Chong, Christoph C. Zielinski, Joshua Tobias, Mirjana Drinic, Teerapat Ungtrakul, Wen-Chi Chou, Li-Yuan Bai, Aumkhae Sookprasert, Jedzada Maneechavakajorn, Suebpong Tanasanvimon, Thomas Cheung Yau, Chia-Jui Yen, Chaiyut Charoentum, Wichit Arpornwirat, Arunee Dechaphunkul, Iurie Bulat, Marina Maglakelidze, Yee Chao, Erika Garner-Spitzer, Ursula Wiedermann
Purpose:HER2/neu is overexpressed in up to 30% of gastroesophageal adenocarcinomas (GEA) and linked to poor prognosis. Recombinant mAbs to treat HER2/neu-overexpressing cancers are effective with limitations, including resistance and toxicity. Theref
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2f60e21e29115932209d40d9524bea17
https://doi.org/10.1158/1078-0432.c.6530562.v1
https://doi.org/10.1158/1078-0432.c.6530562.v1
Autor:
Anthony J. Good, Mark T. Marino, Nicholas J. Ede, Leslie Chong, Christoph C. Zielinski, Joshua Tobias, Mirjana Drinic, Teerapat Ungtrakul, Wen-Chi Chou, Li-Yuan Bai, Aumkhae Sookprasert, Jedzada Maneechavakajorn, Suebpong Tanasanvimon, Thomas Cheung Yau, Chia-Jui Yen, Chaiyut Charoentum, Wichit Arpornwirat, Arunee Dechaphunkul, Iurie Bulat, Marina Maglakelidze, Yee Chao, Erika Garner-Spitzer, Ursula Wiedermann
Supp. Table 1; Supp. Table 2; Supp. Table 3 A,B; Supp. Table 4; Supp. Table 5; Supp. Table 6; Supplementary Data 1; Supplementary Data 2
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0f4b207604681307f928821deb571f02
https://doi.org/10.1158/1078-0432.22480935.v1
https://doi.org/10.1158/1078-0432.22480935.v1
Autor:
Wannapong Triampo, Stefan Schreier, Wichit Arpornwirat, Prapaphan Budchart, Suparerk Borwornpinyo
Publikováno v:
Journal of Circulating Biomarkers
Background: The circulating rare cell population is diverse and rich in diagnostic information. Its characterization and clinical exploitation by cell-based liquid biopsy is an ongoing research task. Bone marrow is one of the major contributors to th
Autor:
Stefan, Schreier, Prapaphan, Budchart, Suparerk, Borwornpinyo, Wichit, Arpornwirat, Panuwat, Lertsithichai, Prakasit, Chirappapha, Wannapong, Triampo
Publikováno v:
Journal of Cancer Research and Clinical Oncology.
Background Breast cancer residual disease assessment in early-stage patients has been challenging and lacks routine identification of adjuvant therapy benefit and objective measure of therapy success. Liquid biopsy assays targeting tumor-derived enti
Autor:
Gerald Goh, Ramona Schmid, Kelly Guiver, Wichit Arpornwirat, Imjai Chitapanarux, Vinod Ganju, Seock-Ah Im, Sung-Bae Kim, Arunee Dechaphunkul, Jedzada Maneechavakajorn, Neil Spector, Thomas Yau, Mehdi Afrit, Slim Ben Ahmed, Stephen R Johnston, Neil Gibson, Martina Uttenreuther-Fischer, Javier Herrero, Charles Swanton
Publikováno v:
PLoS Medicine, Vol 13, Iss 12, p e1002136 (2016)
Inflammatory breast cancer (IBC) is a rare, aggressive form of breast cancer associated with HER2 amplification, with high risk of metastasis and an estimated median survival of 2.9 y. We performed an open-label, single-arm phase II clinical trial (C
Externí odkaz:
https://doaj.org/article/de97a67b8e1f4c658411e84662aa753b
Autor:
Chia Jui Yen, Yee Chao, Wichit Arpornwirat, Joshua Tobias, Marina Maglakelidze, Jedzada Maneechavakajorn, Thomas Yau, Mirjana Drinić, Iurie Bulat, Nicholas J. Ede, Teerapat Ungtrakul, Chaiyut Charoentum, Suebpong Tanasanvimon, Wen-Chi Chou, Aumkhae Sookprasert, Li Yuan Bai, Erika Garner-Spitzer, Arunee Dechaphunkul, Anthony J Good, Leslie Chong, Mark T. Marino, Ursula Wiedermann, Christoph C. Zielinski
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 27(13)
Purpose: HER2/neu is overexpressed in up to 30% of gastroesophageal adenocarcinomas (GEA) and linked to poor prognosis. Recombinant mAbs to treat HER2/neu-overexpressing cancers are effective with limitations, including resistance and toxicity. There
Autor:
Stefano Iacobelli, Malgorzata Foszczynska-Kloda, Soo-Chin Lee, Richard A. Michaelson, Juan Lacava, Raymond Smith, Vichien Srimuninnimit, Mauricio Kotliar, William Audeh, Damir Vrbanec, Young-Hyuck Im, Paola Edith Price, Maria Del Pilar, Barbara Bower, Tadeusz Pienkowski, Jedzada Maneecahvakajorn, Seppo Pyrhoenen, Alexander Marmé, Saverio Cinieri, Vladimir Semiglazov, Luciano Latini, Luis Miguel, Thitiya Sirisinha, Mario Matwiejuk, Jose Luiz Pedrini, John Allan Ellerton, Maik Hauschild, Xiaojia Wang, Christoph Maintz, Joohyuk Sohn, Estefania Monturus, Kenjiro Aogi, Eugeny Gotovkin, Ron Blachy, Douglas Otero Reye, Rita Blanchard, Bahriye Aktas, Adam Knott, Norberto Batista Lopez, L Roman, Reiki Nishimura, Piotr Tomczak, Duncan Wheatley, Emilio Alba Conejo, Yoshinori Itoh, Giraldo Kato, Petar Stefanovski, Rosa Jochim, Christoph Thomssen, Brigitte Van Eyll, Yutaka Tokuda, S O'Reilly, Paulette Blanchet, Ion Boiangiu, Nikola Vasev, Sherko Kümmel, Julie Taguchi, Do Youn Oh, David Miles, Jurandyr Andrade, Nora Giacomi, Volkmar Mueller, Eduardo Côrtes, Paula Klein, Eleonora Restuccia, Xuenong Ouyang, Leanne Budde, Andre Kallab, Elżbieta Starosławska, Takayuki Ueno, Taral Patel, Jun Horiguchi, Gilson Delgado, Sue Prill, Carol Peterson, Lourdes Calvo, Andreas Kirsch, Gustavo Ismael, Liwei Wang, Veena Charu, Dino Amadori, Pirkko Kellokumpu-Lehtinen, Brooke R. Daniel, Frank Senecal, Sanjay Yadav, Vera Gorbunova, Mikhail Kopp, Patrapim Sunpaweravong, Hiroji Iwata, Frank Priou, Kazuhiko Nakagami, Alejandra Perez, Michael R. Clemens, Marcus Schmidt, Denise A. Yardley, Birgitta Wesenberg, Priscilla Caguioa, Haruki Ogata, An Nguyen, Sung Bae Kim, Tsz-Kok Yau, Vladimir Merculov, Mikhail Lichinitser, Valorie Chan, Yoshiaki Rai, Neville Davidson, Walter E. Aulitzky, Gloria Martinez, Koji Takeda, Sherene Loi, Junichiro Watanabe, Louis Fehrenbacher, Gunta Purkalne, Shaker R. Dakhil, Claudia Schumacher, Rizvana Ahmad, Winnie Yeo, Christine Brezden-Masley, Alison Jones, Seock-Ah Im, Zetina Toache, Jeffrey Hargis, Celia Tosello, Tania Soria, Catia Angiolini, Maria De Fatima Gaui, Ravi Patel, Christopher Lobo, Andreas Schneeweiss, Priyanka Sharma, Cesar Estuardo, Randall Thomas, Adam Brufsky, Virote Sriuranpong, Zhenzhou Shen, Sandra Franco, Clive Mulatero, Wojciech Polkowski, Maria Alejandra Bartoli, Shigehira Saji, Patrick J. Flynn, Kimberly L. Blackwell, Gladys Rodriguez, Robert Robles, Timothy J. O'Rourke, Fabio Franke, Gabriel Tellez-Trevilla, Robert R. Carroll, Laura Biganzoli, Cheng Ying, Peter A. Kaufman, Mark Karwal, Mirta Varela, Darcy Spicer, Jonathan Polikoff, Roberto Hegg, Jungsil Ro, Pedro Sánchez-Rovira, Takahiro Nakayama, Edda Simoncini, María Bianconi, Liljana Kostovska-Maneva, Hugo Castro, Elza Grincuka, Jeff Neidhart, Anne Robinson, Nathan B. Green, Robert Hermann, Laura Assersohn, Teresa Gamucci, Dennis Tudtud, Nobuaki Sato, Antonio Gonzalez Martin, Victor Hugo Alencar, Jess Armor, Bruno Coudert, Nuria Ribelles, Eva Ciruelos, Daniel Cubero, Iveta Kudaba, Eduardo Cronemberger, Norikazu Masuda, Norio Kohno, Sergio J Azevedo, Vadim Shirinkin, Miguel Gil I Gil, Serafin Morales, Hirofumi Fujii, Chris Gallagher, Hernandez Monroy, Katsumasa Kuroi, Rodrigo Moura, Richy Agajanian, Zeljko Soldic, Jean-Marc Ferrero, Kenichi Inoue, Mark C. Benyunes, Davi Jendiroba, Filippo Montemurro, Masahiro Kashiwaba, Robert Quackenbush, Koichiro Tsugawa, Paulo M. Hoff, Eva-Maria Grischke, Susana De La Cruz, Vincent Hansen, Marianna Bitina, Carolyn B. Hendricks, Javier Cortes, Zee Wan Wong, Igor Kiselev, David Waterhouse, Javier Hornedo Muguiro, Mario Campone, Marianne Just, Emma Clark, Rodrigo Pereira, Sandra M Swain, Ruemu E. Birhiray, Helio Pinczowski, Wichit Arpornwirat
Publikováno v:
The Lancet. Oncology. 21(4)
Summary Background CLEOPATRA was a phase 3 study comparing the efficacy and safety of pertuzumab, trastuzumab, and docetaxel with placebo, trastuzumab, and docetaxel in patients with HER2-positive metastatic breast cancer. In the primary analysis and
Autor:
Jung Ho Sohn, Wichit Arpornwirat, O Ocak Arikan, Y-C Chang, Roberta Valenti, Patricia Bastick, S-A Im, Hong-Ling Xue, KS Lee, Kadri Altundag, Alper Sevinc, TH Le, Hikmat Abdel-Razeq, Aycin Canatar, Y-H Im, Jae Ho Jeong, Ruchan Uslu, Rajnish Nagarkar, H-S Park, S-B Kim
Publikováno v:
Cancer Research. 76:P4-13
Background BOLERO-2 phase III trial established the efficacy of everolimus (EVE) plus exemestane (EXE) for the treatment of postmenopausal patients with hormone receptor (HR)-positive, HER2-negative, advanced breast cancer (aBC). However, in this stu
Autor:
Chia Jui Yen, Thomas Yau, Aumkhae Sookprasert, Erika Garner-Spitzer, Chaiyut Charoentum, Arunee Dechaphunkul, Yee Chao, Suebpong Tanasanvimon, Teerapat Ungtrakul, Wen-Chi Chou, Ursula Wiedermann, Jedzada Maneechavakajorn, Iurie Bulat, Nick Ede, Leslie Chong, Marina Maglakelidze, Christoph C. Zielinski, Wichit Arpornwirat, Li Yuan Bai, Anthony J Good
Publikováno v:
Cancer Research. 79:CT059-CT059
Background: HER2/neu is overexpressed in 15-25% of gastric cancer patients and associated with poor prognosis. Alternative treatments to monoclonal antibodies are needed due to cost and global availability issues of mAbs. Thus a B-cell peptide vaccin